Department of Endodontics, Faculty of Dentistry, Gazi University, Ankara, Turkey.
Int Endod J. 2014 Mar;47(3):222-7. doi: 10.1111/iej.12129. Epub 2013 May 8.
To evaluate the efficacy of a single buccal infitration using 4% articaine hydrochloride (HCl) with 1 : 100,000 epinephrine or 4% articaine HCl with 1 : 100 000 epinephrine bitartrate for obtaining adequate pulpal anaesthesia in the palatal roots of maxillary first molars associated with irreversible pulpitis.
In this single-blind randomized clinical trial, fifty subjects were randomly allocated to receive maxillary buccal injections of 1.5 mL 4% articaine with 1 : 100,000 epinephrine (n = 25) or 1.5 mL 4% articaine with 1 : 100,000 epinephrine bitartrate (n = 25). Visual analogue scale (VAS) scores and pulse rate measurements were recorded during access cavity preparation and initial file placement into the mesiobuccal, distobuccal and palatal canals. Data were analysed using Duncan and t-tests.
There was no significant difference between the two anaesthetic solutions regarding the VAS scores and pulse rate measurements during endodontic procedures. The mean VAS ratings of the 50 patients during file placement into the palatal canals were significantly higher compared with the other three root canal procedures (P < 0.0001). The heart rates during negotiation of palatal canals were significantly higher than when negotiating the mesiobuccal and distobuccal canals (P < 0.0001).
Single buccal infiltration did not achieve adequate pulpal anaesthesia in the palatal root canal of the maxillary first molars associated with irreversible pulpitis.
评估在伴有不可复性牙髓炎的上颌第一磨牙腭根中,使用 4%盐酸阿替卡因(HCl)加 1:100000 肾上腺素或 4%盐酸阿替卡因加 1:100000 酒石酸肾上腺素进行单次颊侧浸润注射以获得足够牙髓麻醉的效果。
在这项单盲随机临床试验中,将 50 名受试者随机分为两组,分别接受 1.5 mL 4%盐酸阿替卡因加 1:100000 肾上腺素(n = 25)或 1.5 mL 4%盐酸阿替卡因加 1:100000 酒石酸肾上腺素(n = 25)的上颌颊侧注射。在制备开髓腔和初次进入近中颊、远中颊和腭根管时,记录视觉模拟评分(VAS)和脉搏率测量值。使用 Duncan 和 t 检验对数据进行分析。
在牙髓治疗过程中,两种麻醉溶液的 VAS 评分和脉搏率测量值之间没有显著差异。50 名患者在腭根管内放置器械时的平均 VAS 评分明显高于其他三个根管治疗程序(P < 0.0001)。在腭根管内探查时的心率明显高于在近中颊和远中颊根管内探查时的心率(P < 0.0001)。
单次颊侧浸润注射未能在上颌第一磨牙伴有不可复性牙髓炎的腭根中获得足够的牙髓麻醉效果。